NEW YORK (GenomeWeb News) – A pair of studies appearing in Nature Genetics yesterday reported on a number of variants linked to myeloma, including a variant located near a gene involved in telomere function and ones linked to the cohesin complex.
A new program launched by the Institute of Cancer Research in the UK and the Royal Marsden NHS Foundation Trust, a London-based cancer center, aims to bring cancer predisposition gene testing to all cancer patients in the UK.
NEW YORK (GenomeWeb News) – A collection of London research institutes and hospitals have banded together to launch an initiative to develop genetically tailored treatments for thousands of lung cancer patients, the Institute for Cancer Research said today.
NEW YORK (GenomeWeb News) – A set of studies stemming from the Collaborative Oncological Gene-environment Study, or COGS, have roughly doubled the number of common genetic variants implicated in prostate, breast, or ovarian cancer.
Oxford Gene Technology, a British genetics and biomarker research firm, announced this week that it has taken a license to a series of microRNAs that the company aims to develop into a blood-based prognostic/diagnostic for prostate cancer.
NEW YORK (GenomeWeb News) – The Institute of Cancer Research, London has granted Oxford Gene Technology a license to develop a panel of diagnostic and prognostic prostate cancer microRNA biomarkers into a new assay, OGT said today.
NEW YORK (GenomeWeb News) – The Institute for Cancer Research, London plans to launch a new center that will conduct genomic profiling of patients' cancer tumors, and it wants to raise £3.2 million ($5.1 million) to fund the venture.
NEW YORK (GenomeWeb News) – Two new loci have been linked to elevated risk for a childhood embryonal kidney cancer called Wilms tumor, according to a study appearing online yesterday in Nature Genetics.